Vision Financial Markets’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$138K Sell
5,752
-1,493
-21% -$39.1K 0.12% 92
2026
Q1
$203K Buy
7,245
+7
+0.1% +$186 0.2% 67
2025
Q4
$180K Sell
7,238
-493
-6% -$12.4K 0.18% 67
2025
Q3
$197K Sell
7,731
-493
-6% -$12.2K 0.17% 74
2025
Q2
$199K Buy
8,224
+8
+0.1% +$187 0.19% 71
2025
Q1
$208K Sell
8,216
-2,443
-23% -$63.9K 0.23% 62
2024
Q4
$283K Buy
+10,659
New +$289K 0.3% 49

Other funds holding PFE

Vision Financial Markets's PFE Position: Q2 2026 in Review

Vision Financial Markets reduced its Pfizer (PFE) stake by 21% in Q2 2026, selling an estimated $39.1K and leaving 5,752 shares worth $138K. The position accounts for 0.12% of the portfolio, ranked #92.

Vision Financial Markets first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $283K in Q4 2024. 1,113 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Vision Financial Markets held 5,752 shares of Pfizer worth $138K as of Q2 2026.
  • Vision Financial Markets sold 1,493 Pfizer shares in Q2 2026, an estimated $39.1K.
  • Pfizer made up 0.12% of Vision Financial Markets's portfolio in Q2 2026, its #92 holding.
  • Vision Financial Markets first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Vision Financial Markets's Pfizer position peaked at $283K in Q4 2024.
  • 1,113 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vision Financial Markets's 13F filing for Q2 2026, filed 24 Jul 2026.